COVID-19 Vaccine Makers Plan for Annual Boosters, but It's Not Clear They'll Be Needed.
Published in JAMA
COVID-19 Vaccine Makers Plan for Annual Boosters, but It's Not Clear They'll Be Needed.
Effect of Use of a Bougie vs Endotracheal Tube With Stylet on Successful Intubation on the First Attempt Among Criticall...
...
Published in JAMA
For critically ill adults undergoing emergency tracheal intubation, failure to intubate the trachea on the first attempt occurs in up to 20% of cases and is associated with severe hypoxemia and cardiac arrest. Whether using a tracheal tube introducer ("bougie") increases the likelihood of successful intubation compared with using an endotracheal tu...
Diagnostic Excellence Through the Lens of Patient-Centeredness.
Published in JAMA
After 12 Years, NIH Director Francis S. Collins Seeks His Next Chapter.
Published in JAMA
Contraception Requirements in Clinical Trials: Considerations From Studies on Sexually Transmitted Infections.
Published in JAMA
Trials Test Mushrooms and Herbs as Anti-COVID-19 Agents.
Published in JAMA
Bariatric Surgery as a Strategy for Improving Outcomes in Nonalcoholic Steatohepatitis.
Published in JAMA
Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Non...
...
Published in JAMA
No therapy has been shown to reduce the risk of serious adverse outcomes in patients with nonalcoholic steatohepatitis (NASH). To investigate the long-term relationship between bariatric surgery and incident major adverse liver outcomes and major adverse cardiovascular events (MACE) in patients with obesity and biopsy-proven fibrotic NASH without c...
Frequency and Duration of Boarding for Pediatric Mental Health Conditions at Acute Care Hospitals in the US.
Published in JAMA
Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical...
...Published in JAMA
The evidence for benefit of convalescent plasma for critically ill patients with COVID-19 is inconclusive. To determine whether convalescent plasma would improve outcomes for critically ill adults with COVID-19. The ongoing Randomized, Embedded, Multifactorial, Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP) enrolled and random...
